Cytokinetics Stock Price (NASDAQ:CYTK)

Add to My Stocks
$10.6 $0 (0%) CYTK stock closing price Jan 20, 2017 (Closing)
20 JAN 2017
amigobulls logo
CYTK hand_up
CYTK vs S&P 500
Closing Price: Jan 20, 2017
$10.6 ( 0%)
S&P 500
2271.3 ( 0.34%)
52 Week Price Range
1 Year Return: 31.51%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Cytokinetics Snapshot Video

13 5 2

CYTK Stock Details

Prev Close* : $10.60
Market Cap:
Day Low: $10.4
52 Week Low: $6.00
Open: $10.65
Volume: 201979
Day High: $10.75
52 Week High: $13.45

Latest Stock Market News

Latest Articles

Cytokinetics News - From Partners

What Took So Long?   by Zacks on Dec 29, 2016

CYTK Stockcharts

View CYTK PE ratio, PS ratio stocks charts and compare with peers.
CYTK Chart
Note: Compare Cytokinetics stock price history with the index and industry peers.

Cytokinetics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Cytokinetics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

CYTK Industry Peers

Company Price Change (%)
Mesoblast (MESO)6.120.15 (2.39%)
Intellia Therapeutics (NTLA)12.640.27 (2.09%)
Amgen (AMGN)154.670.87 (0.57%)
Voyager Therapeutics (VYGR)11.050.25 (2.21%)
Biogen Inc (BIIB)280.660.31 (0.11%)
Acorda Therapeutics (ACOR)210.3 (1.45%)
Ionis Pharma (IONS)46.970.27 (0.58%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
NewLink Genetics (NLNK)11.330.54 (5%)
Argos Therapeutics (ARGS)5.050.2 (4.12%)
Halozyme Therapeutics (HALO)11.50.42 (3.79%)
BioDelivery Sciences (BDSI)1.90.05 (2.7%)
Osiris Therapeutics (OSIR)5.040.13 (2.65%)
VIVUS (VVUS)1.190.03 (2.59%)
Amarin (AMRN)2.950.07 (2.43%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jan 21, 2017
CompanyPriceChange (%)
Pluristem Therapeutics (PSTI)1.150.25 (17.86%)
Puma Biotech (PBYI)32.253.25 (9.15%)
Sangamo BioSciences (SGMO)3.650.3 (7.59%)
Five Prime Therapeutics (FPRX)43.52.58 (5.6%)
Stemline Therapeutics (STML)10.40.6 (5.45%)
Sarepta Therapeutics (SRPT)32.661.57 (4.59%)
Inovio Pharma (INO)6.280.3 (4.56%)
Top losers from Medical-Biomed-Genetics industry
* As of Jan 21, 2017

Cytokinetics Financial Statements

income statement20152014201320122011
Net Sales Or Revenues28.65M46.94M30.64M7.55M4M
Net Income-37.5M-14.64M-33.71M-40.37M-47.86M
Total Operating Expense66.05M61.68M64.54M48.01M51.96M
view Cytokinetics, Inc. income statement
balance sheet20152014201320122011
Total Assets115.23M132.96M83.18M77.55M52.77M
Total Liabilities46.64M40.9M28.74M7.46M4.59M
Shareholders Equity68.59M92.06M54.44M70.08M48.17M
view Cytokinetics, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities37.24M-34.01M22.04M2.61M-2.29M
Net Cash From (Used By) Operating Activities4.88M-44.84M-7.71M-33.43M-45.59M
Increase (Decrease) In Prop Plant And Equipment-0.56M-1.1M-0.52M-0.12M-0.44M
view Cytokinetics, Inc. cashflow statement

Cytokinetics Stock Message Board

Cytokinetics stock price ended the last trading day at 10.6. Looking at Cytokinetics market capitalization, which currently stands at 430.53M, we can say that CYTK stock is a Small cap stock. Cytokinetics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: Cytokinetics stock price and Cytokinetics share price mean the same thing. 201979 CYTK shares were traded yesterday, and Cytokinetics stock chart shows that the CYTK stock quote hit a day high of 10.75 and day low of 10.4. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Cytokinetics does not pay dividends. Cytokinetics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.